1. Home
  2. MIRA vs HUGE Comparison

MIRA vs HUGE Comparison

Compare MIRA & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • HUGE
  • Stock Information
  • Founded
  • MIRA 2020
  • HUGE 1998
  • Country
  • MIRA United States
  • HUGE Canada
  • Employees
  • MIRA N/A
  • HUGE N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIRA Health Care
  • HUGE Health Care
  • Exchange
  • MIRA Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • MIRA 10.2M
  • HUGE 7.8M
  • IPO Year
  • MIRA 2023
  • HUGE N/A
  • Fundamental
  • Price
  • MIRA $2.56
  • HUGE $0.15
  • Analyst Decision
  • MIRA
  • HUGE
  • Analyst Count
  • MIRA 0
  • HUGE 0
  • Target Price
  • MIRA N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • MIRA 10.8M
  • HUGE 2.6M
  • Earning Date
  • MIRA 09-13-2024
  • HUGE 09-12-2024
  • Dividend Yield
  • MIRA N/A
  • HUGE N/A
  • EPS Growth
  • MIRA N/A
  • HUGE N/A
  • EPS
  • MIRA N/A
  • HUGE N/A
  • Revenue
  • MIRA N/A
  • HUGE N/A
  • Revenue This Year
  • MIRA N/A
  • HUGE N/A
  • Revenue Next Year
  • MIRA N/A
  • HUGE N/A
  • P/E Ratio
  • MIRA N/A
  • HUGE N/A
  • Revenue Growth
  • MIRA N/A
  • HUGE N/A
  • 52 Week Low
  • MIRA $0.51
  • HUGE $0.13
  • 52 Week High
  • MIRA $6.95
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 61.22
  • HUGE 38.67
  • Support Level
  • MIRA $0.62
  • HUGE $0.14
  • Resistance Level
  • MIRA $5.01
  • HUGE $0.16
  • Average True Range (ATR)
  • MIRA 0.50
  • HUGE 0.01
  • MACD
  • MIRA 0.29
  • HUGE 0.01
  • Stochastic Oscillator
  • MIRA 45.56
  • HUGE 58.97

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: